Preventing and treating cancer in people living with HIV
Consortium for Advancing Management and Prevention of Cancer in People with HIV
This program tests new ways to prevent and treat cancers that affect people living with HIV through clinical trials and global research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11406609 on NIH RePORTER |
What this research studies
You would join a long-running network that runs clinical trials to test prevention and treatment approaches for cancers seen in people with HIV. The consortium connects 39 clinical sites in the U.S., sub‑Saharan Africa, and Latin America and pairs patient trials with lab-based research using blood and tissue samples. Studies can include prevention measures, new drug or therapy combinations, and biologic studies to understand why cancers occur and how they respond to treatment. Patient advocates and community boards help guide which questions get studied and how trials are conducted.
Who could benefit from this research
Good fit: People living with HIV who have, or are at increased risk for, HIV‑related cancers (such as anal cancer) and who can attend one of the AMC trial sites are likely candidates.
Not a fit: People without HIV or whose cancer type is not included in current AMC trials are unlikely to be eligible or directly benefit from these studies.
Why it matters
Potential benefit: If successful, this work could lower cancer rates and improve treatments and survival for people living with HIV.
How similar studies have performed: Yes — the AMC has run many prior trials that produced practice-changing results and improved care for people with HIV-related cancers.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.